Notice Regarding the Recognition of Non-operating Income, Non-operating Expenses and Income Taxes - Deferred
AnGes,Inc. and consolidated subsidiary EmendoBio Inc.
Interest received on bank deposits, the revaluation of the US dollar-denominated loan to consolidated subsidiary EmendoBio Inc. due to fluctuations in foreign exchange rates, registration and license taxes and share registrar fees incurred in connection with the exercise of stock acquisition rights, interest on the second series of unsecured corporate bonds (private placement bonds), and a review of the recoverability of deferred tax assets.
Interest received: ¥3,778 thousand; foreign exchange gain: ¥385,413 thousand; stock issuance costs: ¥2,163 thousand; bond interest: ¥2,641 thousand; income tax adjustments: ¥2,829 thousand. Recognized as non-operating income, non-operating expenses and income tax adjustments.
Cumulative consolidated first-quarter period of the fiscal year ending December 2026 (1 January 2026 to 31 March 2026)
The disclosure states that details should be referred to in the earnings report for the first quarter of the fiscal year ending December 2026, to be disclosed today.
| Item | Details |
|---|---|
| Event name | Notice Regarding the Recognition of Non-operating Income, Non-operating Expenses and Income Taxes - Deferred |
| Subject Entity | AnGes,Inc. and consolidated subsidiary EmendoBio Inc. |
| Cause | Interest received on bank deposits, the revaluation of the US dollar-denominated loan to consolidated subsidiary EmendoBio Inc. due to fluctuations in foreign exchange rates, registration and license taxes and share registrar fees incurred in connection with the exercise of stock acquisition rights, interest on the second series of unsecured corporate bonds (private placement bonds), and a review of the recoverability of deferred tax assets. |
| Amount of Impact on Business Performance | Interest received: ¥3,778 thousand; foreign exchange gain: ¥385,413 thousand; stock issuance costs: ¥2,163 thousand; bond interest: ¥2,641 thousand; income tax adjustments: ¥2,829 thousand. Recognized as non-operating income, non-operating expenses and income tax adjustments. |
| Accounting period in which recognized | Cumulative consolidated first-quarter period of the fiscal year ending December 2026 (1 January 2026 to 31 March 2026) |
| Outlook | The disclosure states that details should be referred to in the earnings report for the first quarter of the fiscal year ending December 2026, to be disclosed today. |
Items this document does not state (19)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The revaluation of the US dollar-denominated loan due to fluctuations in foreign exchange rates, interest received on bank deposits, registration and license taxes and share registrar fees incurred in connection with the exercise of stock acquisition rights, bond interest incurred, and the write-off of deferred tax assets following a review of their recoverability.